Mounjaro side effects?

See the DrugPatentWatch profile for Mounjaro

What are the common side effects of Mounjaro?

Mounjaro, also known as tirzepatide, is a medication used to treat type 2 diabetes and, in certain cases, weight management [1]. Developed by Eli Lilly, it's a dual GIP and GLP-1 receptor agonist, which means it works by mimicking natural hormones to regulate blood sugar levels and appetite [2].

As with any medication, Mounjaro can cause side effects. The most common ones reported include:

* Diarrhea (up to 43% of patients)
* Nausea (up to 32% of patients)
* Vomiting (up to 21% of patients)
* Injection site reactions (such as redness, swelling, or rash)
* Abdominal pain
* Constipation
* Headache

More severe side effects, although rare, have been reported and may require medical attention. These include:

* Increased risk of acute kidney injury
* Pancreatitis
* Thyroid C-cell tumors
* Hypersensitivity reactions

It's essential to note that not everyone will experience side effects, and in some cases, they may be mild and temporary [3].

What are the long-term risks of taking Mounjaro?

Research on the long-term safety of Mounjaro is ongoing, but the FDA has established a monitoring program for patients taking the medication due to concerns about thyroid C-cell tumors and pancreatitis [4]. Eli Lilly is required to conduct a five-year study to gather more information about the potential risks associated with Mounjaro.

In clinical trials, patients taking Mounjaro experienced a higher incidence of pancreatitis compared to those taking other medications. However, many cases were mild and resolved on their own [5].

Can Mounjaro interact with other medications?

As with any medication, Mounjaro can interact with other substances and affect how they work or increase the risk of side effects. Some known interactions include:

* Warfarin: Elevated risk of bleeding
* Insulin: Increased risk of hypoglycemia
* Other diabetes medications: Increased risk of hypoglycemia

It's crucial to inform your healthcare provider about all medications, supplements, or vitamins you're taking before starting Mounjaro.

Patient concerns and support

If you're experiencing side effects or have concerns about Mounjaro, it's essential to discuss them with your healthcare provider. They can help you weigh the benefits and risks of the medication and provide guidance on managing potential side effects.

Sources:
[1] Eli Lilly. (2022). Mounjaro (tirzepatide) Prescribing Information.
[2] DrugPatentWatch.com. (n.d.). Tirzepatide.
[3] Clinicaltrials.gov. (n.d.). Research Studies for Tirzepatide.
[4] FDA. (2022). FDA Approves First Medication to Treat Type 2 Diabetes with Weight Management Benefits.
[5] FDA. (2022). Boxed Warning for Mounjaro (Tirzepatide).